cookies-img
We use third-party cookies to provide support. By continuing to browse this website, you accept our privacy policy.
close-icon
Immunic Inc
7 own
6 watching
Current Price
$1.21
$-0.07
(-5.47%)
arrow-icon
1 Week Returns
3 Months Returns
1 Year Returns

Get Started with as little as $1.00

Market Capitalization
Market Capitalization
62.05M
52-Week High
52-Week High
3.11000
52-Week Low
52-Week Low
0.94500
Average Volume
Average Volume
0.18M
Dividend Yield
Dividend Yield
--
P/E Ratio
P/E Ratio
--
iconMarket Capitalization62.05M
icon52-Week High3.11000
icon52-Week Low0.94500
iconAverage Volume0.18M
iconDividend Yield--
iconP/E Ratio--
What does the Immunic Inc do?
Immunic, Inc., a clinical-stage biopharmaceutical company, develops a pipeline of selective oral immunology therapies for the treatment of chronic inflammatory and autoimmune diseases. Its lead development program is IMU-838, which is in Phase 2 clinical for treatment of relapsing-remitting multiple sclerosis, inflammatory bowel disease, and other chronic inflammatory and autoimmune diseases, as well as to treat coronavirus disease. The company is also developing IMU-935, an inverse agonist of ROR?t; and IMU-856 for the restoration of the intestinal barrier function in patients suffering from diseases, such as inflammatory bowel disease, irritable bowel syndrome with diarrhea, immune checkpoint inhibitor induced colitis, and other intestinal barrier function diseases. Immunic, Inc. is headquartered in New York, New York.
Read More
How much money does Immunic Inc make?
News & Events about Immunic Inc.
Ticker Report
1 year ago
Immunic, Inc. (NASDAQ:IMUX Get Rating) Investment analysts at Wedbush issued their FY2027 earnings estimates for Immunic in a research note issued to investors on Tuesday, January 31st. Wedbush analyst L. Moussatos expects that the company will post earnings per share of ($1.62) for ...
PR Newswire
1 year ago
Thinking about buying stock in Macy's, Immunic, LexinFintech, Provention Bio, or Clearside Biomedical? Thinking about buying stock in Macy's, Immunic, LexinFintech, Provention Bio, or Clearside Biomedical? PR Newswire NEW YORK, Nov. 17, 2022 NEW YORK, Nov. 17, 2022 /PRNewswire...
Ticker Report
1 year ago
SVB Leerink cut shares of Immunic (NASDAQ:IMUX Get Rating) from an outperform rating to a market perform rating in a research report report published on Friday, MarketBeat reports. SVB Leerink currently has $5.00 price target on the stock. A number of other analysts have also commented on ...
PR Newswire
1 year ago
Thinking about buying stock in Myovant Sciences, Sellas Life Sciences, Borr Drilling, Mullen Automotive, or Immunic? Thinking about buying stock in Myovant Sciences, Sellas Life Sciences, Borr Drilling, Mullen Automotive, or Immunic? PR Newswire NEW YORK, Oct. 24, 2022 NEW YORK, Oct. 24, 2022...
PR Newswire
1 year ago
Thinking about buying stock in T2 Biosystems, WISeKey, Immunic, Meta Materials, or Applied DNA Sciences? Thinking about buying stock in T2 Biosystems, WISeKey, Immunic, Meta Materials, or Applied DNA Sciences? PR Newswire NEW YORK, Oct. 13, 2022 NEW YORK, Oct. 13, 2022 /PRNewswire...
Frequently Asked Questions
Frequently Asked Questions
What is Immunic Inc share price today?
plus_minus_icon
Can Indians buy Immunic Inc shares?
plus_minus_icon
How can I buy Immunic Inc shares from India?
plus_minus_icon
Can Fractional shares of Immunic Inc be purchased?
plus_minus_icon
What are the documents required to start investing in Immunic Inc stocks?
plus_minus_icon
What is today’s traded volume of Immunic Inc?
plus_minus_icon
What is today’s market capitalisation of Immunic Inc?
plus_minus_icon
What is the 52-Week High and Low Range of Immunic Inc?
plus_minus_icon
What percentage is Immunic Inc down from its 52-Week High?
plus_minus_icon
What percentage is Immunic Inc up from its 52-Week Low?
plus_minus_icon
Current Price
$1.21
$-0.07
(-5.47%)
arrow-icon
1 Week Returns
3 Months Returns
1 Year Returns

Get Started with as little as $1.00

Related Stocks
ADC Therapeutics SA
ADC Therapeutics SA
$4.96
$0.52 (11.71 %)
Veru Inc
Veru Inc
$1.16
$-0.09 (-7.20 %)
Taysha Gene Therapies Inc
Taysha Gene Therapies Inc
$2.45
$-0.13 (-4.85 %)
Allovir Inc
Allovir Inc
$0.75
$0.01 (2.04 %)
Sign up and dive into a whole new world of investing.
Join over 370,000 who have signed up and are using Stockal successfully already.
Related Stocks
ADC Therapeutics SA
ADC Therapeutics SA
$4.96
$0.52 (11.71 %)
Veru Inc
Veru Inc
$1.16
$-0.09 (-7.20 %)
Taysha Gene Therapies Inc
Taysha Gene Therapies Inc
$2.45
$-0.13 (-4.85 %)
Allovir Inc
Allovir Inc
$0.75
$0.01 (2.04 %)
Sign up and dive into a whole new world of investing.
Join over 370,000 who have signed up and are using Stockal successfully already.

              Borderless Investing Inc., (“Borderless Investing”), the owner of the Stockal Platform, is not a broker-dealer nor an investment advisor and through its affiliate stockbroker Stockal Securities Pvt. Ltd., (SEBI INZ000301236), acting as the introducing entity has entered into a clearing agreement with DriveWealth LLC., to offer U.S. equities on the Stockal Platform. The Stockal Platform enables investments in a diverse set of global assets from a single account from anywhere in the world. As such, Borderless Investing makes no warranties or representations, express or implied, on products and services offered through its website/platform. It accepts no liability for any damages or losses, however, caused in connection with the use of related services.

              All investments involve risk and returns will fluctuate, are subject to market volatility and may cause losses. The material on this website/platform is provided solely for informational and educational purposes and shall not in any manner be considered a recommendation or endorsement of any strategy or investment, nor an offer to sell or a solicitation of an offer to buy securities, products or services nor advice. Borderless Investing makes no guarantee as to the currency, accuracy, or quality of information published and/or archived on this website/platform, nor will Borderless Investing accept any responsibility for other organizations, businesses, and private persons that provide information on this website/platform. All information on this website/platform regarding products and services provided by Borderless Investing is subject to change without notice. Reasonable efforts are taken to ensure the accuracy and integrity of all information provided here, but Borderless Investing is not responsible for misprints, out of date information, or errors. Any investment decision and/or strategy that investors make or employ, whether or not such decision or strategy derives from or relies upon material accessed or provided through this website/platform, is undertaken at the investor’s sole discretion and risk. Before making any investment decisions, investors should consult additional sources of information and/or their legal or tax advisor. PLEASE READ THIS FULL DISCLOSURE CAREFULLY BEFORE USING THIS SERVICE. BY USING THE SERVICE OR CLICKING AGREE YOU ARE AGREEING TO BE BOUND BY THESE DISCLOSURES AND ALL TERMS AND CONDITIONS ON THIS WEBSITE/PLATFORM.

              *DriveWealth LLC., a member of the Securities Investor Protection Corporation (SIPC), will serve as the custodian for your securities account. In the event that DriveWealth LLC., fails and is placed in liquidation under the Securities Investor Protection Act, securities in your brokerage account may be protected up to $500,000. For details, please see www.sipc.org.

              All brands and logos used on this website are the property of their respective owners.

              Foreside Fund Services acts as the distributor to the DriveWealth ICE 100 Index ETF and is not affiliated with Borderless Investing Inc, DriveWealth LLC, BlackOak Investors LP, ACR Group, or other entities referenced on this website.

              Get Started with as little as $1.00